缺少SRC-2联合激活剂会导致类似于格尔克病的糖原异常症
Atul R Chopra1, Jean-Francois Louet, Pradip Saha
1Department of Molecular and Cellular Biology, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA.
概括
转录协激活剂SRC-2通过调节G6Pase酶来控制肝脏葡萄糖的产生. 在小鼠中,SRC-2 缺陷模仿了 Von Gierke 的表现.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 肝脏的葡萄糖生产对于大脑功能和生存至关重要.
- 葡萄糖-6-酸酶 (G6Pase) 是释放葡萄糖到血中的关键酶.
- 在G6Pase的突变导致·吉尔克病 (糖原储存疾病-1a).
研究的目的:
- 为了确定禁食肝脏葡萄糖释放的调节者.
- 调查转录协激活剂SRC-2在葡萄糖代谢中的作用.
- 阐明SRC-2控制G6Pase表达的机制.
主要方法:
- 研究了SRC-2在调节禁食肝脏葡萄糖释放中的作用.
- 分析了SRC-2与孤儿核受体RORalpha的直接相互作用.
- 在小鼠模型中检查了SRC-2剥离 (全身和肝脏特异性) 的影响.
主要成果:
- 鉴定出SRC-2是快腹肝血糖释放的调节剂.
- SRC-2直接调节G6Pase的表达,作为与RORalpha.pha一起的协活性剂.
- 在小鼠中SRC-2切除导致了·吉尔克病表型.
结论:
- SRC-2 是肝脏G6Pase表达的关键调节者.
- SRC-2在控制哺乳动物葡萄糖生产方面发挥着至关重要的作用.
- SRC-2对于预防吉尔克病表型至关重要.
相关概念视频
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Incomplete Dominance
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Epistasis Analysis
Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...


